|
针灸联合昂丹司琼片治疗胃肠肿瘤化疗患者胃肠道反应的效果观察
|
Abstract:
目的:评价针灸联合昂丹司琼片的针药结合的治疗策略在胃肠肿瘤化疗患者胃肠道反应中的干预效果。方法:受试对象来自于我院2022年4月至2023年4月收治的80例胃肠肿瘤化疗患者,排除因颅内转移、胃肠道梗阻导致的中枢性呕吐或器质性病变性呕吐患者后,结合盲法分组原则将患者依次纳入对照组(n = 40,予以昂丹司琼治疗)与研究组(n = 40,实施针灸联合昂丹司琼治疗),评价两组主要疗效、肝功能生化指标、安全性指标、营养状况。结果:较对照组,研究组患者症状积分水平更低(P < 0.05),同时血清胆红素等肝功能生化指标水平更低(P < 0.05),且血清白蛋白等营养状况指标水平更高(P < 0.05),此外两组不良反应发生构成比比较无统计学意义(P > 0.05)。结论:中医针灸配合昂丹司琼片形成的针药结合的治疗策略在满足了胃肠肿瘤化疗患者对胃肠道反应治疗需求的同时,也兼顾了安全性,价值显著,疗效确切,具有积极的应用前景。
Objective: To evaluate the intervention efficacy of acupuncture combined with ondansetron tablets, a treatment strategy combining acupuncture and medicine, in the gastrointestinal response of patients with gastrointestinal tumor chemotherapy. Methods: Subjects were derived from 80 patients with gastrointestinal tumor chemotherapy admitted to our hospital from April 2022 to April 2023. After excluding patients with central vomiting due to intracranial metastasis, gastrointestinal obstruction, or vomiting due to organic lesions, patients were included in the control group (n = 40, ondansetron) and the study group (n = 40, acupuncture with ondansetron) in accordance with the principle of blinded grouping, to evaluate the main efficacy, biochemical index of liver function, safety index and nutritional status of the two groups. Results: Compared with the control group, the study group had a lower symptom score (P < 0.05), a lower biochemical level of liver function such as serum bilirubin (P < 0.05), and a higher level of nutritional status such as serum albumin (P < 0.05), and the composition ratio of adverse reactions was not statistically significant (P > 0.05). Conclusion: The treatment strategy of acupuncture and medicine formed by Chinese acupuncture and moxibustion and ondansetron tablets not only meets the needs of gastrointestinal tumor chemotherapy patients for the treatment of gastrointestinal response, but also takes into account the safety, with significant value and definite efficacy, and has a positive application prospect.
[1] | 蔡俊媛, 陈启庭, 张广路, 等. 健脾益气方联合穴位贴敷防治乳腺癌化疗后胃肠道反应临床研究[J]. 现代中西医结合杂志, 2020, 29(3): 274-277. |
[2] | 彭巍, 谭盐梅. 针灸联合药物治疗胃肠肿瘤化疗患者胃肠道反应的疗效[J]. 内蒙古中医药, 2021, 40(7): 125-126. |
[3] | 岑必福. 针灸联合药物治疗胃肠肿瘤化疗病人胃肠道反应的疗效分析[J]. 医药前沿, 2018, 8(14): 323. |
[4] | 胡悦. 芳香疗法联合昂丹司琼预防治疗对胰腺癌化疗患者胃肠道反应、疲乏及睡眠的影响[J]. 医学理论与实践, 2024, 37(11): 1956-1958. |
[5] | 黄山鉴, 杨保庆, 黄奎源, 等. 福沙匹坦双葡甲胺联合昂丹司琼治疗化疗性胃肠道反应的临床效果[J]. 广西医学, 2022, 44(13): 1471-1474. |
[6] | 卢焕章, 李嘉怡, 吴瑞兰, 等. 揿针埋针联合中药热奄包对肠癌围化疗期胃肠道反应及生活质量的影响[J]. 现代中西医结合杂志, 2022, 31(13): 1828-1832. |
[7] | 黄雪青, 杨柳, 武伟龙, 等. 针灸联合昂丹司琼片治疗胃肠肿瘤化疗患者胃肠道反应的效果观察[J]. 中国实用医刊, 2023, 50(9): 121-123. |
[8] | 古旭莹, 高志清, 张子敬, 等. 温针灸对结肠癌术后腹腔热灌注化疗患者胃肠道反应的影响[J]. 针刺研究, 2020, 45(4): 315-319. |
[9] | 庄语, 于冬冬, 马田田, 等. 隔姜灸联合揿针对恶性肿瘤化疗患者胃肠道反应的影响[J]. 针刺研究, 2024, 49(7): 700-706. |
[10] | 陆丹红, 许坚. 隔物灸联合阿瑞匹坦及昂丹司琼对晚期肺癌含顺铂方案化疗所致恶心呕吐的预防效果研究[J]. 陕西中医, 2020, 41(8): 1084-1087. |